← Back to Search

Automated Reminders for Colorectal Cancer Screening

N/A

Recruiting

Led By Connie L Arnold, PhD

Research Sponsored by Louisiana State University Health Sciences Center Shreveport

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 45 to 75 (based on USPSTF guidelines)

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 years

Awards & highlights

Study Summary

This trial will study a new way to remind patients to get screenings for colorectal cancer, in order to promote longer-term adherence. The new method will use automated calls or text messages, based on patient preference.

Who is the study for?

The PRIME-CRC Trial is for English-speaking individuals aged 45 to 75 who have visited participating rural health clinics in the past year. It's not for those up-to-date with CRC screening, very ill patients, or those with cognitive impairments, significant hearing or vision issues, a family history requiring different screening due to risk factors, or a history of cancer other than non-melanoma skin cancer.Check my eligibility

What is being tested?

This trial tests an educational program designed to help people in rural areas stick with colorectal cancer (CRC) screenings over time. One group gets enhanced usual care; the other also receives automated calls or texts as reminders about test preparations and follow-ups.See study design

What are the potential side effects?

Since this trial focuses on education and communication methods rather than medical treatments, there are no direct side effects from drugs or procedures. However, participants may experience anxiety or stress related to receiving frequent communications about their CRC screenings.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 45 and 75 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

CRC Screening

Trial Design

2Treatment groups

Active Control

Group I: Enhanced Usual CareActive Control2 Interventions

Patients will receive a plain language, literacy appropriate, actionable printed CRC screening handout emphasizing the benefits of CRC screening and screening options; as well as plain language, literacy appropriate handouts on the CRC screening test they choose - colonoscopy or FIT. Patients will receive no reminder calls.

Group II: PRIME CRCActive Control3 Interventions

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Louisiana State University Health Sciences Center ShreveportLead Sponsor

45 Previous Clinical Trials

16,419 Total Patients Enrolled

National Cancer Institute (NCI)NIH

13,665 Previous Clinical Trials

40,925,054 Total Patients Enrolled

Northwestern UniversityOTHER

1,586 Previous Clinical Trials

916,219 Total Patients Enrolled

Media Library

Enhanced Usual Care Clinical Trial Eligibility Overview. Trial Name: NCT04313114 — N/A

Colorectal Cancer Research Study Groups: Enhanced Usual Care, PRIME CRC

Colorectal Cancer Clinical Trial 2023: Enhanced Usual Care Highlights & Side Effects. Trial Name: NCT04313114 — N/A

Enhanced Usual Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04313114 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any more participants needed for this research project?

"Indeed, the information found on clinicaltrials.gov indicates that this trial is still open to enrollment. Originally posted on September 20th 2021 and most recently modified April 11th 2022, it intends to recruit 1200 people from 3 distinct centres of care."

Answered by AI

Is it feasible to become a participant in this investigation?

"As part of this medical trial, 1200 individuals with colorectal carcinoma who are between 45 and 75 years old will be accepted. Additionally, the following criteria must be met: age range as specified by US Preventive Services Task Force (USPSTF) guidelines; fluency in English language; having visited one of the participating Federally Qualified Health Centers at least once over the last year."

Answered by AI

Is the age limitation for this experimental protocol restricted to participants aged 45 or younger?

"According to the criteria for this experiment, only patients aged between 45 and 75 years can apply. Conversely, there are 38 clinical trials available for minors and 1051 opportunities for seniors above 65 years old."

Answered by AI

What is the scope of enrollment for this medical trial?

"Affirmative. The clinical trial, which was first uploaded on the 20th of September 2021, is indeed actively seeking participants as detailed on clinicaltrials.gov. 1200 patients need to be recruited from 3 distinct hospitals for this medical experiment to proceed according to plan."

Answered by AI

Recent research and studies

Contemporary Clinical TrialsJournal

Design of a Randomized Controlled Trial to Assess the Comparative Effectiveness of a Multifaceted Intervention to Improve Three-year Adherence to Colorectal Cancer Screening Among Patients Cared for in Rural Community Health Centers

Davis, Terry C., James D. Morris, Elise H. Reed, Laura M. Curtis, Michael S. Wolf, Adrienne B. Davis, and Connie L. Arnold. 2022. “Design of a Randomized Controlled Trial to Assess the Comparative Effectiveness of a Multifaceted Intervention to Improve Three-year Adherence to Colorectal Cancer Screening Among Patients Cared for in Rural Community Health Centers”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2021.106654.

Contemporary Clinical TrialsJournal

clinicaltrials.govStudy

The PRIME-CRC Trial to Promote CRC Screening in Rural Communities

2021. "The PRIME-CRC Trial to Promote CRC Screening in Rural Communities". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04313114.

All > Colonoscopy